Baca berita tanpa iklan. Gabung Kompas.com+
#Indonesia-japan
News
Indonesia Highlights: AstraZeneca Denies Using Swine Trypsin in Its Covid-19 Vaccine| Mishap at Jakarta’s Halim Airport Causes Diversion of Flights to Soekarno-Hatta Airport | Indonesian Embassy in Ja

Indonesia Highlights: AstraZeneca Denies Using Swine Trypsin in Its Covid-19 Vaccine| Mishap at Jakarta’s Halim Airport Causes Diversion of Flights to Soekarno-Hatta Airport | Indonesian Embassy in Ja

AstraZeneca denies that it uses swine trypsin in Covid-19 vaccine, days before it is finally permitted to be used in Indonesia
News
Indonesia to Receive Antidotes for Acute Kidney Injury from Japan Next Week

Indonesia to Receive Antidotes for Acute Kidney Injury from Japan Next Week

Syahril said the government would distribute them to all referral hospitals for handling cases of kidney failure.
News
Indonesia Receives First Shipment of Over 200K Covid-19 Vaccine Doses from Japan

Indonesia Receives First Shipment of Over 200K Covid-19 Vaccine Doses from Japan

Under the bilateral scheme between both countries, the 1,990,910 doses of the AstraZeneca vaccine will be shipped six times from October 19-22.
News
 Indonesia Highlights: Indonesia to Start Vaccinating Children With the Covid-19 Vaccine | Indonesia to Receive 2 Million Covid-19 Vaccines From Japan in July | Chinese Workers Denied Access to Covid-

Indonesia Highlights: Indonesia to Start Vaccinating Children With the Covid-19 Vaccine | Indonesia to Receive 2 Million Covid-19 Vaccines From Japan in July | Chinese Workers Denied Access to Covid-

Indonesia aims to vaccinate 32.6 million children to protect there from Covid-19. This and more on Indonesia Highlights
News
 Indonesia to Receive 2 Million Covid-19 Vaccines From Japan in July

Indonesia to Receive 2 Million Covid-19 Vaccines From Japan in July

Indonesia is set to receive 2 million Covid-19 vaccines from Japan in July. The vaccines will bolster the country's intensifying vaccination drive
All News
Baca berita tanpa iklan. Gabung Kompas.com+

MOST POPULAR

Close Ads